MOST RECENT
The Engelstad Foundation supported Touro University Nevada's lone biomedical lab when few other funders would. A recent discovery there could lead to new treatments for HIV, and even cancer, Alzheimer’s and more.
Philanthropy makes up only a small fraction of spending on research and support for people with HIV, still a major threat around the world. In the push for a vaccine, Gates and Gilead are leading the pack.
ALS remains a devastating disease, but research is advancing, thanks in large part to the efforts of those impacted. Eric and Amanda Stevens have turned to the athlete and first responder communities to raise awareness and funds.
Among non-communicable diseases, diabetes has a particularly low profile as a global health concern. The Helmsley Charitable Trust has made it a central focus, including two recent commitments to the WHO.
To build up collaborative research infrastructure, a landmark $100 million gift from businessman Gene Lay will launch a new institute spanning Brigham and Women's Hospital, Mass General and Harvard Medical School.
A study commissioned by the Disability & Philanthropy Forum is a must-read for funders aiming to drive social justice for disabled people and address complex and overlapping issues of racial, gender and other inequities.
We can't have too many ways to fight cancer. Here’s who’s backing a nonprofit startup that’s using AI to repurpose generic drugs that could mean the difference between life and death for patients — and solvency or bankruptcy.
Effective altruism has had a rough year, but remains a major force within philanthropy. We take a closer look at two of this EA-driven outfit’s programs: farm animal welfare and biosecurity and pandemic preparedness.
The $78 million gift from a foundation built by an heir to the du Pont fortune will fuel research and clinical care for children with cancer, sickle cell disease and other life-threatening blood disorders.
The Gates Foundation, Novo Nordisk Foundation and Open Philanthropy are collaborating under a partnership called Pandemic Antiviral Discovery, funding research to develop treatments that may be needed for future pandemics.
Stanley and Fiona Druckenmiller have a $1.9 billion foundation and a reported fortune of $10 billion. Here’s a closer look at how the couple makes big bets for economic mobility, the environment and health.
In this candid conversation, the storied investor and mega-donor discusses what he and his wife Fiona look for in grantees, how much they plan to give away, why they won’t sign the Giving Pledge, and more.
With a $100 million commitment, the Howard Hughes Medical Institute is the latest funder backing research to prepare for pathogens with the potential to threaten human health, or even trigger new pandemics.
Paul and Diane Manning, longtime supporters of diabetes research at the University of Virginia, recently committed $100 million to build an advanced biotech research institute there. Here’s a rundown on the gift and the donors.
Sergey Brin’s foundation has nearly $5 billion in assets and a portfolio spanning Parkinson’s disease, science and activism. It’s not known for transparency, but we do know a fair amount about what it supports and why.
As part of IP’s State of American Philanthropy project, we recently published an in-depth paper on trends in cancer research funding. Author Mike Scutari overviews what we learned and offers clues on what to expect going forward.
The Chicago-based Muscular Dystrophy Association is a leading funder in the field of neuromuscular diseases. We check in with Chief Research Officer Dr. Sharon Hesterlee to discuss current challenges and priorities.
The FDA recently approved a new drug to treat ALS. Here’s how the ALS Association, equipped with funding from 2014’s viral Ice Bucket Challenge, contributed to that outcome — and what it’s looking to do next.
Top grantmakers from Asia and the U.S. have joined forces on a new Philanthropy Asia Alliance, and are already backing six on-the-ground projects. The alliance highlights Singapore’s role as a hub for Asian philanthropy.
Since her husband David Koch’s passing in 2019, Julia Koch has kept a fairly low philanthropic profile. But the sheer scale of her fortune means much larger giving may be coming down the line. Here are a few things to look out for.
The Bezos family’s mega-commitment to the Fred Hutchinson Cancer Center will fund cancer and infectious disease research. The gift has a 20-year backstory, and offers a peek at how the fantastically wealthy clan operates.
Once viewed as the “graveyard of neuroscience,” the field of spinal cord injury has made headway thanks to the Christopher & Dana Reeve Foundation. We check in with two leaders to discuss challenges and opportunities.
Philanthropy was more active than usual in last week’s United Nations General Assembly, as the secretary general called for a “rescue mission” to get Sustainable Development Goals on track. Here’s a rundown of the big pledges.
Michael Bloomberg just received his third reappointment as global ambassador for noncommunicable diseases and injuries. The mega-donor shared some insights with IP on how donors can impact global health and more.
The Parkinson's Foundation in the U.S. and Parkinson's U.K. have inked a new partnership to boost investment in treatments for the neurodegenerative condition that affects 10 million people worldwide.
Often missed or misdiagnosed, lupus disproportionately affects women of color in the U.S. Here’s how a leading lupus research funder is speeding along the development of much-needed treatments.
The Africa Frontline First Catalytic Fund is setting its sights on compensating and training community health workers, who play a crucial role in addressing public health problems. Two major foundations have already signed on.
A team of researchers discovered that work on some of the most lethal types of cancer is consistently underfunded. We dig into their findings with co-author Suneel Kamath, MD.
The Open Medicine Foundation supports research into Long COVID, ME/CFS, and other complex, chronic conditions, but research dollars are few and the fallout of these conditions is devastating.
Philanthropic funding has played a major role in a highly successful international effort to combat a disease that was once widespread across the globe. But the fight isn’t over yet.